282
Schneider JL, Goddard KA, Davis J, Wilfond B, Kauffman TL, Reiss JA, Gilmore M, et al. “Is it
worth knowing?” Focus group participants’ perceived utility of genomic preconception carrier
screening. J Genet Couns. 2016;25:135–45.
Schema L, McLaughlin M, Veach PM, LeRoy BS. Clearing the air: a qualitative investiga-
tion of genetic counselors’ experiences of counselor-focused patient anger. J Genet Couns.
2015;24:717–31.
Sebold C, Koil C. Genetic library: grief and bereavement. J Genet Couns. 2009;18:200–3.
Seth SG, Goka T, Harbison A, Hollier L, Peterson S, Ramondetta L, et al. Exploring the role of
religiosity and spirituality in amniocentesis decision-making among Latinas. J Genet Couns.
2011;20:660–73.
Sexton AC, Sahhar M, Thorburn DR, Metcalfe SA. Impact of a genetic diagnosis of a mitochon-
drial disorder 5–17 years after the death of an affected child. J Genet Couns. 2008;17:261–73.
Shaw A, Hurst JA. “What is this genetics, anyway?” Understandings of genetics, illness cau-
sality and inheritance among British Pakistani users of genetic services. J Genet Couns.
2008;17:373–83.
Sheets KM, Baty BJ, Vázquez JC, Carey JC, Hobson WL. Breaking difficult news in a cross-
cultural setting: a qualitative study about Latina mothers of children with down syndrome.
J Genet Couns. 2012;21:582–90.
Sheppard VB, Graves KD, Christopher J, Hurtado-de-Mendoza A, Talley C, Williams KP. African
American women’s limited knowledge and experiences with genetic counseling for hereditary
breast cancer. J Genet Couns. 2014;23:311–22.
Shiloh S. Illness representations, self-regulation, and genetic counseling: a theoretical review. J
Genet Couns. 2006;15:325–37.
Smart A. Impediments to DNA testing and cascade screening for hypertrophic cardiomyopathy and
long QT syndrome: a qualitative study of patient experiences. J Genet Couns. 2010;19:630–9.
Tomlinson AN, Skinner D, Perry DL, Scollon SR, Roche MI, Bernhardt BA. “Not tied up neatly
with a bow”: professionals’ challenging cases in informed consent for genomic sequencing.
J Genet Couns. 2016;25:62–72.
Vos J, Asperen CJ, Oosterwijk JC, Menko FH, Collee MJ, Garcia EG, et al. The counselees’
self-reported request for psychological help in genetic counseling for hereditary breast/ovarian
cancer: not only psychopathology matters. Psychooncology. 2013;22:902–10.
Wakefield CE, Homewood J, Mahmut M, Taylor A, Meiser B. Usefulness of the threatening medi-
cal situations inventory in individuals considering genetic testing for cancer risk. Patient Educ
Couns. 2007;69:29–38.
Weil J. Psychosocial genetic counseling. New York: Oxford University Press; 2000.
Weil J. Resistance and adherence: understanding the patient’s perspective. In: LeRoy BS, McCarthy
Veach P, Bartels DM, editors. Genetic counseling practice. Hoboken: Wiley-Blackwell; 2010.
p. 155–74.
White MT. Making sense of genetic uncertainty: the role of religion and spirituality. Am J Med
Genet C Semin Med Genet. 2009;151C:68–76.
Williams SR, Berrier KL, Redlinger-Grosse K, Edwards JG. Reciprocal relationships: the genetic
counselor-patient relationship following a life-limiting prenatal diagnosis. J Genet Couns.
2017;26:337–54.
Williams-Piehota P, Pizarro J, Schneider TR, Mowad L, Salovey P. Matching health messages
to monitor-blunter coping styles to motivate screening mammography. Health Psychol.
2005;24:58–67.
Wool C, Dudek M. Exploring the perceptions and the role of genetic counselors in the emerging
field of perinatal palliative care. J Genet Couns. 2013;22:533–43.
9 Patient Factors: Resistance, Coping, Affect, andfiStyles